FcγRI is required for TGFβ2-treated macrophage-induced tolerance

Immunobiology

Volumn 218, Issue 9, 2013, Pages 1200-1206

  Gu, Z ^a,b   Chhabra, A Y ^a   Alard, P ^a   Warner, D R ^c   Kosiewicz, M M ^a  

^a University of Louisville School of Medicine   (United States)

^b NANJING MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

Antigen presenting cells; Delayed type hypersensitivity; Fc R; Macrophages; Mice; TGF ; Tolerance

Indexed keywords

FC RECEPTOR; FC RECEPTOR I; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; FCGAMMARI GENE; FEMALE; GENE; GENE EXPRESSION; GENE NUMBER; IMMUNOLOGICAL TOLERANCE; MACROPHAGE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION;

ACAID; ANALYSIS OF VARIANCE; ANOVA; ANTERIOR CHAMBER-ASSOCIATED IMMUNE DEVIATION; ANTIGEN PRESENTING CELLS; APC; CFA; COMPLETE FREUND'S ADJUVANT; DELAYED TYPE HYPERSENSITIVITY; DN; DOMINANT NEGATIVE; DTH; FCΓR; I.V.; INTRAVENOUS; LIPOPOLYSACCHARIDE; LPS; MΦ; MΦ59; MACROPHAGE; MACROPHAGE HYBRIDOMA CELL LINE; MACROPHAGES; MICE; OVA; OVALBUMIN; PEC; PERITONEAL EXUDATES CELLS; S.C.; SUBCUTANEOUS; TGFΒ; TOLERANCE; TRANSFORMING GROWTH FACTOR Β; WILD-TYPE; WT;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; ANTIGEN PRESENTATION; CELL LINE; CELL NUCLEUS; FEMALE; IMMUNE TOLERANCE; LYMPHOCYTE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MICROARRAY ANALYSIS; RECEPTORS, IGG; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; SMAD3 PROTEIN; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA2;

EID: 84880036950     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2013.04.003     Document Type: Article

References (31)

1. Alard P., Clark S.L., Kosiewicz M.M. Mechanisms of tolerance induced by TGF beta-treated APC: CD4 regulatory T cells prevent the induction of the immune response possibly through a mechanism involving TGF beta. Eur. J. Immunol. 2004, 34:1021.
2. Cousins S.W., McCabe M.M., Danielpour D., Streilein J.W. Identification of transforming growth factor-beta as an immunosuppressive factor in aqueous humor. Invest. Ophthalmol. Vis. Sci. 1991, 32:2201.
3. D'Orazio T.J., Mayhew E., Niederkorn J.Y. Ocular immune privilege promoted by the presentation of peptide on tolerogenic B cells in the spleen II. Evidence for presentation by Qa-1. J. Immunol. 2001, 166:26.
4. D'Orazio T.J., Niederkorn J.Y. Splenic B cells are required for tolerogenic antigen presentation in the induction of anterior chamber-associated immune deviation (ACAID). Immunology 1998, 95:47.
5. D'Orazio T.J., Niederkorn J.Y. A novel role for TGF-beta and IL-10 in the induction of immune privilege. J. Immunol. 1998, 160:2089.
6. Granstein R.D., Staszewski R., Knisely T.L., Zeira E., Nazareno R., Latina M., Albert D.M. Aqueous humor contains transforming growth factor-beta and a small (less than 3500 daltons) inhibitor of thymocyte proliferation. J. Immunol. 1990, 144:3021.
7. Gratchev A., Kzhyshkowska J., Kannookadan S., Ochsenreiter M., Popova A., Yu X., Mamidi S., Stonehouse-Usselmann E., Muller-Molinet I., Gooi L., Goerdt S. Activation of a TGF-beta-specific multistep gene expression program in mature macrophages requires glucocorticoid-mediated surface expression of TGF-beta receptor II. J. Immunol. 2008, 180:6553.
8. Guyre C.A., Barreda M.E., Swink S.L., Fanger M.W. Colocalization of Fc gamma RI-targeted antigen with Class I MHC: implications for antigen processing. J. Immunol. 2001, 166:2469.
9. Hara Y., Caspi R.R., Wiggert B., Dorf M., Streilein J.W. Analysis of an in vitro-generated signal that induces systemic immune deviation similar to that elicited by antigen injected into the anterior chamber of the eye. J. Immunol. 1992, 149:1531.
10. Harrison P.T., Davis W., Norman J.C., Hockaday A.R., Allen J.M. Binding of monomeric immunoglobulin G triggers Fc gamma RI-mediated endocytosis. J. Biol. Chem. 1994, 269:24396.
11. Ioan-Facsinay A., de Kimpe S.J., Hellwig S.M., van Lent P.L., Hofhuis F.M., van Ojik H.H., Sedlik C., da Silveira S.A., Gerber J., de Jong Y.F., Roozendaal R., Aarden L.A., van den Berg W.B., Saito T., Mosser D., Amigorena S., Izui S., van Ommen G.J., van Vugt M., van de Winkel J.G., Verbeek J.S. FcgammaRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection. Immunity 2002, 16:391.
12. Kosiewicz M.M., Alard P., Streilein J.W. Alterations in cytokine production following intraocular injection of soluble protein antigen: impairment in IFN-gamma and induction of TGF-beta and IL-4 production. J. Immunol. 1998, 161:5382.
13. Kosiewicz M.M., Okamoto S., Miki S., Ksander B.R., Shimizu T., Streilein J.W. Imposing deviant immunity on the presensitized state. J. Immunol. 1994, 153:2962.
14. Kosiewicz M.M., Alard P., Liang S., Clark S.L. Mechanisms of tolerance induced by transforming growth factor-beta-treated antigen-presenting cells: CD8 regulatory T cells inhibit the effector phase of the immune response in primed mice through a mechanism involving Fas ligand. Int. Immunol. 2004, 16:697.
15. Kosiewicz M.M., Alard P. Tolerogenic antigen-presenting cells: regulation of the immune response by TGF-beta-treated antigen-presenting cells. Immunol. Res. 2004, 30:155.
16. Liu Y.N., Uchida T., Ju S.T., Dorf M.E. Functional analysis of macrophage hybridomas III. Inhibition of lymphocyte blastogenesis and tumor proliferation. Cell. Immunol. 1985, 94:49.
17. Masli S., Turpie B., Hecker K.H., Streilein J.W. Expression of thrombospondin in TGFbeta-treated APCs and its relevance to their immune deviation-promoting properties. J. Immunol. 2002, 168:2264.
18. Masli S., Turpie B., Streilein J.W. Thrombospondin orchestrates the tolerance-promoting properties of TGFbeta-treated antigen-presenting cells. Int. Immunol. 2006, 18:689.
19. Niederkorn J.Y., Mayhew E. Role of splenic B cells in the immune privilege of the anterior chamber of the eye. Eur. J. Immunol. 1995, 25:2783.
20. Streilein J.W., Niederkorn J.Y. Characterization of the suppressor cell(s) responsible for anterior chamber-associated immune deviation (ACAID) induced in BALB/c mice by P815 cells. J. Immunol. 1985, 134:1381.
21. Streilein J.W. Immune regulation and the eye: a dangerous compromise. FASEB J. 1987, 1:199.
22. Sutterwala F.S., Noel G.J., Salgame P., Mosser D.M. Reversal of proinflammatory responses by ligating the macrophage Fcgamma receptor type I. J. Exp. Med. 1998, 188:217.
23. Taylor A.W., Streilein J.W., Cousins S.W. Identification of alpha-melanocyte stimulating hormone as a potential immunosuppressive factor in aqueous humor. Curr. Eye Res. 1992, 11:1199.
24. Taylor A.W., Streilein J.W., Cousins S.W. Immunoreactive vasoactive intestinal peptide contributes to the immunosuppressive activity of normal aqueous humor. J. Immunol. 1994, 153:1080.
25. Takeuchi M., Kosiewicz M.M., Alard P., Streilein J.W. On the mechanisms by which transforming growth factor-beta 2 alters antigen-presenting abilities of macrophages on T cell activation. Eur. J. Immunol. 1997, 27:1648.
26. Takai T., Li M., Sylvestre D., Clynes R., Ravetch J.V. FcR gamma chain deletion results in pleiotrophic effector cell defects. Cell 1994, 76:519.
27. Warner D.R., Pisano M.M., Roberts E.A., Greene R.M. Identification of three novel Smad binding proteins involved in cell polarity. FEBS Lett. 2003, 539:167.
28. Warner D.R., Roberts E.A., Greene R.M., Pisano M.M. Identification of novel Smad binding proteins. Biochem. Biophys. Res. Commun. 2003, 312:1185.
29. Wilbanks G.A., Streilein J.W. Characterization of suppressor cells in anterior chamber-associated immune deviation (ACAID) induced by soluble antigen. Evidence of two functionally and phenotypically distinct T-suppressor cell populations. Immunology 1990, 71:383.
30. Wilbanks G.A., Mammolenti M., Streilein J.W. Studies on the induction of anterior chamber-associated immune deviation (ACAID) III. Induction of ACAID depends upon intraocular transforming growth factor-beta. Eur. J. Immunol. 1992, 22:165.
31. Yehualaeshet T., O'Connor R., Green-Johnson J., Mai S., Silverstein R., Murphy-Ullrich J.E., Khalil N. Activation of rat alveolar macrophage-derived latent transforming growth factor beta-1 by plasmin requires interaction with thrombospondin-1 and its cell surface receptor, CD36. Am. J. Pathol. 1999, 155:841.